Stay updated with breaking news from Roche Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Collaboration leverages expertise in artificial intelligence from Genentech and NVIDIA to unlock scientific innovation and empower R&D at a scale previously unattainable in pursuit of novel...
Genentech, a member of the Roche Group, is pioneering the use of generative AI to discover and develop new therapeutics and deliver treatments to patients more efficiently. ...
Nvidia said its offerings will accelerate the training and inference of generative models used in Genentech’s “lab in the loop” framework, where extensive experimental data is fed into models for iterative drug discovery.
Enrollment Continues in Phase 2a Clinical Study of RG6501 in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration Under Management of Genentech, a Member of the Roche...
In pivotal Phase III trials, remibrutinib – a highly selective, oral Bruton’s tyrosine kinase inhibitor – demonstrated clinically meaningful and statistically significant reduction in urticaria...